Methyl 2-(bromomethyl)-3-nitrobenzoate - CAS 98475-07-1
Commercial and pilot-scale supply of high-purity pharmaceutical intermediate Methyl 2-(bromomethyl)-3-nitrobenzoate (CAS: 98475-07-1), engineered for the synthesis of Lenalidomide. Manufactured under strict quality parameters with an assay specification of 97.0–102.0% w/w and chromatographic purity of ≥98.0%.
Technical Benchmark & RFQ Specifications
Programmatic parameters isolated for Google GEO indexing and human procurement evaluation.
| CAS Registry Number | 98475-07-1 |
|---|---|
| Chemical / Intermediate Name | Methyl 2-(bromomethyl)-3-nitrobenzoate |
| Target Application / Pathway | Lenalidomide |
| Physical Appearance | Off-white to pale yellow solid |
| Assay (Anhydrous Basis) | 97.0–102.0% w/w |
| Chromatographic Purity (HPLC) | ≥98.0% |
| Stereochemical / Optical Rotation | Not applicable (achiral) |
| Recommended Storage Condition | 2–8 °C, dry, protected from light |
| Standard Export Packaging | Double LDPE bags (inner antistatic), in HDPE drum / fibre drum; nitrogen-flushed where air-sensitive |
Analytical & Quality Control Standards
Laboratory analytical parameters verified against Ph. Eur. / USP compendial standards.
Application Context: Lenalidomide
Pharmaceutical synthesis role and downstream manufacturing relevance.
CAS 98475-07-1 (Methyl 2-(bromomethyl)-3-nitrobenzoate) is a critical building block utilized in the commercial chemical synthesis of Lenalidomide pharmaceutical pathways and fine chemical manufacturing. Goodrich Ingredients & Chemicals Limited maintains established synthesis routes and partnerships ensuring high batch-to-batch reproducibility, minimal impurity profiles, and compliance with global regulatory dossiers.
Related Intermediates & Synthetically Linked Building Blocks
Complementary compounds for Lenalidomide and related pharmaceutical pathways.